ISS / RiskMetrics Recommends Charles River Shareholders Vote Against WuXi Acquisition

NEW YORK, July 26 /PRNewswire/ -- ISS / RiskMetrics Group has recommended that Charles River Laboratories International, Inc. (NYSE: CRL) shareholders vote against the proposed acquisition of WuXi PharmaTech (Cayman) Inc. (NYSE: WX), JANA Partners announced today.  JANA Partners noted that Glass Lewis & Co. also recommended last week that Charles River shareholders vote against the proposed acquisition.  JANA Partners has voiced its strong opposition to this proposed acquisition, and applauds these recommendations.

SOURCE JANA Partners